Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease

Bioorg Med Chem. 2015 Feb 15;23(4):668-80. doi: 10.1016/j.bmc.2015.01.005. Epub 2015 Jan 8.

Abstract

To discover multifunctional agents for the treatment of Alzheimer's disease (AD), a series of scutellarein carbamate derivatives were designed and synthesized based on the multitarget-directed ligand strategy. Their acetylcholinesterase and butyrylcholinesterase inhibitory activities, antioxidant activities, metal-chelating properties and neuroprotective effects against hydrogen peroxide induced PC12 cell injury were evaluated in vitro. The results showed that most of the synthetic compounds exhibited good multifunctional activities. In particular, compound 15c exhibited dual inhibitory potency on acetylcholinesterase and butyrylcholinesterase with IC50 values of 0.57 and 22.6μM, respectively, and good antioxidative activity, with a value 1.3-fold of Trolox. In addition, 15c acted as a selective biometal chelator and possessed neuroprotective effects. Furthermore, 15c could cross the blood-brain barrier (BBB) in vitro and had significant neuroprotective effects in scopolamine-induced cognitive impairment in mice. Taken together, these results suggest that compound 15c might be a potential multifunctional agent for the treatment of AD.

Keywords: Alzheimer’s disease; Antioxidant activity; Cholinesterase inhibitors; Metal-chelating agents; Neuroprotective effects; Scutellarein carbamate derivatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism
  • Animals
  • Antioxidants / chemistry
  • Antioxidants / pharmacokinetics
  • Antioxidants / therapeutic use*
  • Apigenin / chemistry
  • Apigenin / pharmacokinetics
  • Apigenin / therapeutic use*
  • Blood-Brain Barrier / metabolism
  • Butyrylcholinesterase / metabolism
  • Carbamates / chemistry
  • Carbamates / pharmacokinetics
  • Carbamates / therapeutic use
  • Cell Line
  • Chelating Agents / chemistry
  • Chelating Agents / pharmacokinetics
  • Chelating Agents / therapeutic use*
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / pharmacokinetics
  • Cholinesterase Inhibitors / therapeutic use*
  • Cognition / drug effects*
  • Glucuronates / chemistry
  • Glucuronates / pharmacokinetics
  • Glucuronates / therapeutic use*
  • Humans
  • Mice
  • Molecular Docking Simulation
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / pharmacokinetics
  • Neuroprotective Agents / therapeutic use*
  • Rats

Substances

  • Antioxidants
  • Carbamates
  • Chelating Agents
  • Cholinesterase Inhibitors
  • Glucuronates
  • Neuroprotective Agents
  • scutellarin
  • Apigenin
  • Acetylcholinesterase
  • Butyrylcholinesterase